Nonsteroidal anti-inflammatory drug use and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 11, 2001, Pages 1213-1217

  Cotterchio, Michelle ^a,b   Kreiger, Nancy ^a,b   Sloan, Margaret ^a   Steingart, Allan ^c  

^a Cancer Care Ontario   (United States)

^b Departments of Public Health Sciences   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; RISK;

EID: 0035174790     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Proportion of breast cancer cases in the United States explained by well-established risk factors
2. Colon cancer chemoprevention: Clinical development of aspirin as a chemopreventive agent
3. The prevention of colorectal cancer by aspirin use
4. Determination of who may derive most benefit from aspirin in primary prevention: Subgroup results from a randomised control trial
5. Aspirin use and lung, colon, and breast cancer incidence in a prospective study
6. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer
7. Nonsteroidal anti-inflammatory drugs and breast cancer
8. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer
9. Prospective study of regular aspirin use and the risk of breast cancer
10. Nonsteroidal anti-inflammatory drugs and cancer
11. Modulation of rat mammary carcinogensis by indomethacin
12. Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene
13. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiating-promotion protocol
14. Chemoprevention of breast cancer in rats by celecoxib, a COX-2 inhibitor
15. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer
16. Chemoprevention of cancer
17. Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer
18. Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzop-dioxin
19. Sulfone metabolite of suldinac inhibits mammary carcinogenesis
20. An application of capture-recapture methods to the estimation of completeness of cancer registries
21. Improvements in cumulative response rates following implementation of financial incentive
22. Simulation study by confounder-selection strategies
23. Modeling and variable selection in epidemiologic analysis
24. Breast cancer and NSAID use: Heterogeneity of effect in a case control study
25. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene
26. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): An extension of the dietary fat hypothesis of breast cancer
27. Antidepressant medication use and breast cancer risk
28. The effects of NSAIDs on breast cancer prognostic factors
29. Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells
30. Arachidonic acid transformation and tumor production
31. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer